This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Determining eligibility for tax loss harvesting with dividend ETFs involves understanding lot identification, wash sale rules, and cost basis calculations.
15,468 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A high-stakes media merger is drawing political attention and investor caution. Eight Senate Democrats are pressing D...
Markets edged lower in March as crypto regulation chatter intensified. Circle CRCL led the headlines with a sharp mov...
NVIDIA stock struggled over the last week despite solid earnings. This guide breaks down the reasons behind the move ...
As data needs soar, memory makers like Micron Technology face a pivotal five-year horizon. This guide breaks down the...
Citigroup is up about 14% year-to-date through mid-July 2026, outpacing Bank of America and Wells Fargo. AI-driven tr...
Energy Transfer is shifting from a pure yield play to a growth story as key midstream projects advance. This long-for...
Meta Platforms is pursuing a bold path toward a $9 trillion market cap by 2031. This article breaks down the feasibil...
As NetApp gears up for 2026 earnings, investors should focus on cloud services growth, margins, and free cash flow. T...
When a memory-stock rally hits the headlines, you want the real story behind the move. This guide explains why sandis...
Microsoft is at a crossroads as investors await the July 29 results. This article dives into why the stock could rebo...
An in-depth look at Warner Bros. Discovery (WBD) earnings, how its streaming ambitions intersect with legacy TV, and ...